|
This groundbreaking
study analyzes how leading pharmaceutical companies are strategically
leveraging the medical liaison function. As a subscriber to this
study, you will learn how to best maximize the use of this type of
personnel. For each target company, the study provides the
following information:
 | Strategic approach
to the medical liaison function |
 | Response to OIG
guidelines |
 | Organizational
structure/reporting relationships by title |
 | Distribution of
personnel by business unit/therapeutic area |
 | Key roles by title
|
 | Typical salary range
by title |
 | Description of
incentive package by title |
 | Evaluation methods |
The study also analyzes
each company's philosophy about the medical liaison function, including:
 | Quantitative and
qualitative methods for valuing the function |
 | Implications
of Office of Inspector General guidelines and recent litigation on the
liaison role |
* Save 5% -- Mention "PharmCast.com" when
purchase.
To receive more information about the study,
please click on the
following "Request for Info" link.
|